ADVFN Logo ADVFN
시장 데이터
뉴스
도구
시장
팔로우

Hot Features

피드 팔로우

Follow Feed 커뮤니티에서 거래자 및 투자자와 연결하세요.

실시간 옵션 플로우

포괄적인 옵션 데이터를 탐색하고 옵션 흐름으로 고급 필터를 사용하세요.

모니터

터미널 모니터로 주식 및 자산 관심 목록을 구성하고 모니터링하세요.
로그인 Premium Icon프리미엄 Help Menu
S&P 500
5,099.96
1.02%
US Tech 100
17,244.80
1.57%
다우존스 지수
38,239.66
0.40%
Bitcoin
62,952.13
-0.72%
Registration Strip Icon for discussion 같은 생각을 가진 투자자들과 토론할 수 있는 활발한 포럼에서 상호 작용하려면 등록하세요.
등록
  1. 홈
  2. 인베스팅
  3. 주식
  4. 미국
  5. NASDAQ
  6. Iovance Biotherapeutics Inc (IOVA)

  7. Iovance Biotherapeutics Inc (IOVA) 뉴스

IOVA Iovance Biotherapeutics Inc

11.63
0.09 (0.78%)
27 4월(4) 2024 - 마감
15분 지연
기업명 주식 심볼 시장 주식 타입
Iovance Biotherapeutics Inc IOVA 나스닥 보통주
  가격 변동 가격 변동 % 주식 가격 최근 거래 시간
Upgrade Icon
0.09 0.78% 11.63 13:00:12
개장가 저가 고가 종가 전일 종가
11.60 11.335 11.80 11.64 11.54
시세 정보 더보기 »

최근 뉴스

일자 시간 출처 제목
25/04/202405:01GLOBEIovance Biotherapeutics to Present Clinical and..
20/04/202406:15GLOBEIovance Biotherapeutics Reports Inducement Grants under..
23/03/202406:30GLOBEIovance Biotherapeutics Reports Inducement Grants under..
07/03/202408:17EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/03/202407:56EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/03/202407:53EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/03/202407:52EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/03/202407:52EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/03/202407:51EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/03/202407:50EDGAR2Form 4 - Statement of changes in beneficial ownership of..
04/03/202422:00EDGAR2Form 8-K - Current report
04/03/202420:30GLOBEIovance Biotherapeutics Announces FDA has Lifted Clinical..
02/03/202407:00GLOBEIovance Biotherapeutics to Present at Upcoming Conferences
29/02/202421:30EDGAR2Form 8-K - Current report
29/02/202406:05EDGAR2Form 8-K - Current report
29/02/202406:01GLOBEIovance Biotherapeutics Reports Fourth Quarter and Full Year..
23/02/202406:53EDGAR2Form 8-K - Current report
22/02/202422:45GLOBEIovance Biotherapeutics to Host Fourth Quarter and Full-Year..
22/02/202406:44EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
21/02/202407:23EDGAR2Form 8-K - Current report
21/02/202406:21EDGAR2Form 4 - Statement of changes in beneficial ownership of..
20/02/202420:30GLOBEIovance Biotherapeutics, Inc. Announces Pricing of $211..
20/02/202420:03EDGAR2Form 8-K - Current report
17/02/202407:30GLOBEIovance Biotherapeutics Reports Inducement Grants under..
17/02/202405:38GLOBEIovance Biotherapeutics to Host Conference Call and Webcast..
17/02/202405:19GLOBEIovance’s AMTAGVI™ (lifileucel) Receives U.S. FDA..
14/02/202420:16EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
20/01/202407:15GLOBEIovance Biotherapeutics Reports Inducement Grants under..
19/01/202408:09EDGAR2Form 4 - Statement of changes in beneficial ownership of..
19/01/202408:09EDGAR2Form 4 - Statement of changes in beneficial ownership of..
19/01/202408:07EDGAR2Form 4 - Statement of changes in beneficial ownership of..
09/01/202407:03EDGAR2Form 8-K - Current report
28/12/202321:27IHMARKETNEWSWall Street Highlights: Amazon to Introduce Ads on Prime..
28/12/202307:00EDGAR2Form 8-K - Current report
27/12/202321:54DJNIovance Shares Fall Premarket As FDA Places Study On Hold..
27/12/202321:00GLOBEIovance Biotherapeutics Announces Clinical Program Update..
23/12/202307:15GLOBEIovance Biotherapeutics Reports Inducement Grants under..
18/11/202307:00GLOBEIovance Biotherapeutics Reports Inducement Grants under..
08/11/202307:15EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
08/11/202306:05EDGAR2Form 8-K - Current report
08/11/202306:01GLOBEIovance Biotherapeutics Reports Third Quarter and..
01/11/202305:01GLOBEIovance Biotherapeutics to Host Third Quarter and..
31/10/202322:05GLOBEIovance Biotherapeutics to Present Clinical and Pre-Clinical..
21/10/202306:15GLOBEIovance Biotherapeutics Reports Inducement Grants under..
19/10/202309:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
19/10/202309:04EDGAR2Form 4 - Statement of changes in beneficial ownership of..
19/10/202309:03EDGAR2Form 4 - Statement of changes in beneficial ownership of..
16/10/202321:15GLOBEIovance Biotherapeutics Announces Clinical Data for..
28/09/202305:01GLOBEIovance Biotherapeutics to Present Clinical and Pre-Clinical..
23/09/202307:25GLOBEIovance Biotherapeutics Reports Inducement Grants under..

최근 히스토리

NASDAQ
IOVA
Iovance Biotherapeutics
Delayed Upgrade Clock
ADVFN Logo

대한변국
회사 소개
사업
Popular
앱 받기

도움 및 지원받기: kr-support@advfn.com

ADVFN 서비스 이용은 ADVFN의 이용약관에 동의하는 것입니다 이용약관

© 2024 ADVFN PLC - 모든 권리 보유